Abstract
To determine the possibility that methyl substitution in 26- and 27-positions of 24R,25-dihydroxyvitamin D3 [24,25(OH)2D3] alters activities of the original compound, the effects of 24,25(OH)2D3 on calcium (Ca) regulating activity were compared with those of its methyl analog [24,25(OH)2(CH3)2D3] in addition to 1α,25-dihydroxyvitamin D3 [1,25(OH)2D3]. 24,25(OH)2D3 at 10-6 M and 24,25(OH)2(CH3)2D3 at 10-7 M and above significantly stimulated both bone resorption in neonatal mouse calvaria cultures and formation of osteoclast-like multinucleated cells (MNC) in mouse bone marrow cultures. A stimulative effect of 1,25(OH)2D3 on bone resorption and MNC formation was recognized in very low concentrations (10-11 M and above). Although a potency of 24,25(OH)2(CH3)2D3 in stimulating bone calcium (Ca) mobilization and intestinal Ca transport was higher than that of 24,25(OH)2D3, the potencies of both compounds were similar to that of 1,25(OH)2D3 unlike in vitro experiments. As 1,24R,25-trihydroxy-26,27-dimethylvitamin D3 showed almost the same effect as 24,25(OH)2(CH3)2D3, the dihydroxy form is suggested to be hydroxylated at 1α position and converted to trihydroxy form in vitamin D-deficient rats. From these results, methyl substitution in 26- and 27-position of 24,25(OH)2D3 was found to elevate Ca regulating activity of the original compound. In addition, it is suggested that the basis for a similarity in potency between 1,25(OH)2D3 and 24,25(OH)2D3 or its dimethyl analog in vitamin D-deficient rats is likely the result of 1 α-hydroxylation.
Similar content being viewed by others
References
Nakamura T, Kurokawa T, Orimo H (1988) Increase of bone volume in vitamin D-repleted rats by massive administration of 24R,25(OH)2D3. Calcif Tissue Int 43:235–243
Nakamura T, Kurokawa T, Orimo H (1992) Increased bone volume and reduced bone turnover in vitamin D-repleted rabbits by the administration of 24R,25-dihydroxyvitamin D3. Bone 13: 229–236
Reeve J, Tellez M, Green JR, Russell RGG, Mawer EB, Meunier PJ (1982) Long-term treatment of osteoporosis with 24,25-dihydroxycholecalciferol. Acta Endocrinol 101:636–640
Harada M, Miyahara T, Miyata M, Tomita I, Okayachi H, Ikemoto Y, Higuchi S, Otomo S, Kozuka H, Ikekawa N (1992) Effects on cultured neonatal mouse calvaria of 1α,25-dihydroxyvitamin D3, 26,26,26,27,27,27-hexafluoro-1α,25-dihydroxyvitamin D3 and 26,26,26,27,27,27-hexafluoro-1α,23S,25-trihydroxyvitamin D3. Bone Miner 18:41–49
Harada M, Miyahara T, Miyata M, Komiyama H, Sugure A, Ikemoto Y, Kondo S, Takamura T, Higuchi S, Otomo S, Kozuka H, Ikekawa N (1993) Calcium regulating activity of 24a-homo-24,25-difluoro-1α,25-dihydroxyvitamin D3 and 26,27-dimethyl-24,25-difluoro-1α,25-dihydroxyvitamin D3. Calcif Tissue Int 53:318–323
Miyahara T, Harada M, Miyata M, Sugure A, Ikemoto Y, Takamura T, Higuchi S, Otomo S, Kozuka H, Ikekawa N (1992) Calcium regulating activity of 26,27-dialkyl analogs of 1α,25-dihydroxyvitamin D3. Calcif Tissue Int 51:218–222
Seino Y, Yamaoka K, Ishida M, Yabuuchi H, Ichikawa M, Ishige H, Yoshino H, Avioli LV (1982) Biochemical characterization of 1,25-dihydroxyvitamin D receptor in chick embryonal duodenal cytosol. Calcif Tissue Int 34:265–269
Haddad JG, Chyu KJ (1971) Competitive protein-binding radioassay for 25-hydroxycholecalciferol. J Clin Endocrinol 33:992–995
Shigeno C, Yamamoto I, Dokoh S, Hino M, Aoki J, Yamada K, Morita R, Kaneyama M, Torizuka K (1985) Identification of 1,24(R)-dihydroxyvitamin D3-like bone resorbing lipid in a patient with cancer-associated hypercalcemia. J Clin Endocrinol Metab 61:761–768
Takahashi N, Yamana H, Yoshiki S, Roodman GD, Mundy GR, Jones ST, Boyde A, Suda T (1988) Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures. Endocrinology 122:1373–1382
Burstone MS (1958) Histochemical demonstration of acid phosphatase with naphthol AS-phosphate. J Natl Cancer Inst 21: 523–539
Suda T, DeLuca HF, Tanaka Y (1970) Biological activity of 25-hydroxyergocalciferol in rats. J Nutr 100:1049–1052
Connerty HV, Briggs AR (1966) Determination of serum calcium by means of orthocresolphthalein complexone. Am J Clin Pathol 45:290–296
Omdahl J, Holick MF, Suda T, Tanaka Y, DeLuca HF (1971) Biological activity of 1,25-dihydroxycholecalciferol. Biochemistry 10:2935–2940
Matsumoto T, Yamato H, Okazaki R, Kumegawa M, Ogata E (1992) Effect of 24,25-dihydroxyvitamin D3 in osteoclasts. Proc Soc Exp Biol Med 200:161–164
Okano T (1992) Possible roles of vitamin D-transport proteins in the expression of biological activities of vitamin D. Vitamins (Japan) 66:65–78
Reinhardt TA, Ramberg CF, Horst RL (1989) Comparison of receptor binding, biological activity, and in vivo tracer kinetics for 1,25-dihydroxyvitamin D3 and 1,25-dihydroxyvitamin D2, and its 24 epimer. Arch Biochem Biophys 273:64–71
Vargas S, Bouillon R, Van-Baelen H (1990) Effects of vitamin D-binding protein on bone resorption stimulated by 1,25-dihydroxyvitamin D3. Calcif Tissue Int 47:164–168
Tanaka Y, DeLuca HF, Ikekawa N, Morisaki M, Koizumi N (1975) Determination of stereochemical cofiguration of the 24-hydroxy group of 24,25-dihydroxyvitamin D3 and its biological importance. Arch Biochem Biophys 170:620–626
Boris A (1977) Structure-activity relationships of vitamin D analogues. Am J Med 62:543–544
Yamato H, Okazaki R, Ishii T, Ogata E, Sato T, Kumegawa M, Akaogi K, Taniguchi N, Matsumoto T (1993) Effect of 24R,25-dihydroxyvitamin D3 on the formation and function of osteoclastic cells. Calcif Tissue Int 52:255–260
Akatsu T, Takahashi N, Udagawa N, Sato K, Nagata N, Moseley JM, Martin TJ, Suda T (1989) Parathyroid hormone (PTH)-related protein is a potent stimulator of osteoclast-like multinucleated cell formation on the same extent as PTH in mouse marrow cultures. Endocrinology 125:20–27
Klem KH, Jablonski G, Saether O, Jarosz G, Gautvik KM, Gordeladze LO (1990) 1,25-dihydroxyvitamin D-3 and 24,25-dihydroxyvitamin D-3 affect parathormone (PTH)-sensitive adenylate cyclase activity and alkaline phosphatase secretion of osteoblastic cells through different mechanisms of action. Biochim Biophys Acta 1054:304–310
Takahashi N, Akatsu T, Udagawa N, Sasaki T, Yamaguchi A, Moseley JM, Martin TJ, Suda T (1988) Osteoblastic cells are involved in osteoclast formation. Endocrinology 123:2600–2602.
Mortensen BM, Aarseth HP, Ganss R, Haug E, Gautvik KM, Gordeladze JO (1993) 24,25-dihydroxy vitamin D3 treatment inhibits parathyroid-stimulated adenylate cyclase in iliac crest biopsies from uremic patients. Bone 14:125–131
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Miyahara, T., Harada, M., Kondo, S. et al. Calcium regulating activity of 26,27-dimethyl analog of 24R,25-dihydroxyvitamin D3 . Calcif Tissue Int 55, 190–197 (1994). https://doi.org/10.1007/BF00425874
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00425874